![Peter Clausen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Clausen
Directeur des opérations chez NUO THERAPEUTICS, INC.
Fortune : 442 256 $ au 31/05/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
David Jorden | M | 61 | 16 ans | |
C. Winzer | M | 67 |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 22 ans |
Paul Mintz | M | 75 | 7 ans | |
Scott Pittman | M | 65 | 8 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Dean E. Tozer | M | 57 | 2 ans | |
Sherry S. Challberg | M | - |
Marligen Biosciences, Inc.
![]() Marligen Biosciences, Inc. BiotechnologyHealth Technology Marligen Biosciences, Inc. develops, manufactures and distributes healthcare products and services. The company was founded in October 2001 and is headquartered in Ijamsville, MD. | - |
Andrew Scott Maslan | M | 54 | 8 ans | |
Martin P. Rosendale | M | 66 | 7 ans | |
Joe Del Guercio | M | 52 | 5 ans | |
James S. Benson | M | 84 | 9 ans | |
Steven Shallcross | M | 62 | 2 ans | |
John A. Cottingham | M | 69 |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 8 ans |
Craig B. Mendelsohn | M | 69 | 3 ans | |
Lawrence S. Atinsky | M | 55 | 4 ans | |
Stephen Keith | M | 71 | 8 ans | |
Carelyn P. Fylling | F | 76 | 17 ans | |
Rick S. Kent | M | 74 | 2 ans | |
Lyle A. Hohnke | M | 80 | 3 ans | |
Patrick Paul Vanek | M | 68 | 5 ans | |
Mark T. McLoughlin | M | 68 | 11 ans | |
David P. Crews | M | 61 | 8 ans | |
Warner R. Broaddus | M | - |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 6 ans |
Edward L. Field | M | 59 | 2 ans | |
Thomas H. Adams | M | 81 |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 9 ans |
Lewis J. Shuster | M | 68 |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 1 ans |
Arun Kumar Deva | M | 79 | 4 ans | |
Gary R. Otto | M | - | - | |
Donald G. Munroe | M | 67 |
Invitrogen Corp.
![]() Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | 8 ans |
Cathryn J. Hope | F | - | - | |
Jennifer Linsky | F | - | 3 ans | |
Andrew Cohen | M | - | 2 ans | |
Shaun M. Martin | M | - | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 32 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Peter Clausen
- Réseau Personnel